Ron Bentsur
2013 - Keryx Biopharmaceuticals
In 2013, Ron Bentsur earned a total compensation of $5.1M as Former Chief Executive Officer at Keryx Biopharmaceuticals, a 611% increase compared to previous year.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Non-Equity Incentive Plan | $225,000 |
| Option Awards | $144,525 |
| Salary | $300,000 |
| Stock Awards | $4,205,500 |
| Total | $5,050,025 |
Bentsur received $4.2M in stock awards, accounting for 83% of the total pay in 2013.
Bentsur also received $175K in bonus, $225K in non-equity incentive plan, $144.5K in option awards and $300K in salary.
Rankings
In 2013, Ron Bentsur's compensation ranked 1,260th out of 12,286 executives tracked by ExecPay. In other words, Bentsur earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,260 out of 12,286 | 90th |
Division Manufacturing | 412 out of 4,612 | 91st |
Major group Chemicals And Allied Products | 113 out of 1,466 | 92nd |
Industry group Drugs | 74 out of 1,160 | 94th |
Industry Pharmaceutical Preparations | 65 out of 890 | 93rd |
Source: SEC filing on April 15, 2016.
Bentsur's colleagues
We found one more compensation record of an executive who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2013.
2013
James Oliviero
Keryx Biopharmaceuticals